Trial intelligence / Profile preview

Effect of diltiazem and CYP3A5 polymorphism on tacrolimus concentrations in Thai kidney transplant recipients

TCTR20170206005Enrolling by invitation

Sponsor
Chulalongkorn University
Start
Mar 2017
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of tacrolimus in Kidney allograft status (RTx), sponsored by Chulalongkorn University. Started Mar 2017; status: enrolling by invitation.

02

Drugs

tacrolimus
03

Conditions

Kidney allograft status (RTx)

Beyond the preview

Go deeper on TCTR20170206005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170206005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call